Hints and tips:
...Enjoy your weekend, Elaine Moore Deputy head of Lex...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Innovation in rescue & recovery Milbank Innovation in transformational deals Sullivan & Cromwell Innovation in data analytics Shearman & Sterling Innovation in dispute resolution Cravath, Swaine & Moore...
...John Moore, a virologist at Cornell University, said the key question was whether the populations receiving each vaccine were comparable because local factors such as who is prioritised for each vaccine...
...Patrick Moore, a professor at the University of Pittsburgh Cancer Institute, said: “The data itself is not strong, but it is certainly going in a direction that is supportive of this vote.”...
...Yet it is meant to produce about a quarter of the 2.5bn doses Pfizer and BioNTech pledged this year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Lockstep compensation, which ties pay to time served, was devised by the revered US firm Cravath, Swaine & Moore in the 19th century....
...UK ministers and media branded Monday “V-Day” as the first doses of the Pfizer/BioNTech vaccine were administered....
...Mr Greene has also worked on many complex M&A deals, including pharmaceutical company Mylan’s pending $50bn combination with Upjohn, a division of Pfizer....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...Burns joined the firm in 2001 from Cravath Swaine & Moore. John Williams has been appointed president of the Federal Reserve Bank of New York....
...Kevin Phillips of Moore Stephens, a professional services firm, said: “The challenge would be to secure this benefit without also crystallising a taxable gain in the US as Pfizer transferred its foreign...
...Scott Barshay, partner at Cravath, Swaine & Moore, says: “Activist hedge fund activity has been a game-changer....
...The FT’s Malcolm Moore has lunched with Fifa president Sepp Blatter....
...Another hostile deal in the pharma sector was avoided thanks in part to early decisions taken by executives at US drugmaker Mylan and their advisers, including lawyers from Cravath, Swaine & Moore....
.... …………………………………………………………………………………………………………… Ben Hall, world news editor, picks: • Isis Inc: how oil fuels jihadi terrorists by Erika Solomon, Guy Chazan and Sam Jones• Why China’s ‘migrant miracle’ is...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...Apple continued to defy every known logic of gadgetry, even the price-killing effects of Moore’s Law. Asian companies are racing to catch up....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Iran ready to cut Europe’s oil at once - Facebook to file IPO listing details next week - RBS Chairman Sir Philip Hampton turned down £1.4m bonus before Stephen Hester was awarded £1m - Pfizer...
...Amy Schulman, Executive vice-president and general counsel, Pfizer Since setting up the Pfizer Legal Alliance, a flat-fee structure for 19 of the pharmaceutical company’s law firms, Amy Schulman has gone...
...Capsugel, a wholesale pill casings manufacturer acquired by KKR from Pfizer for $2.4bn in April, sold €325m of notes last week, which yielded 9.875 per cent on issuance....
International Edition